Skip to Content

1,408 Results Found

  • Review
  • Open Access
9 Citations
4,197 Views
16 Pages

In Search of Spinal Muscular Atrophy Disease Modifiers

  • Daria Chudakova,
  • Ludmila Kuzenkova,
  • Andrey Fisenko and
  • Kirill Savostyanov

18 October 2024

The 5q Spinal Muscular Atrophy (SMA) is a hereditary autosomal recessive disease caused by defects in the survival motor neuron (SMN1) gene encoding survival motor neuron (SMN) protein. Currently, it is the leading cause of infantile mortality worldw...

(This article belongs to the Special Issue Neurodegenerative Diseases: From Molecular Mechanisms to Pathophysiology)
  • Article
  • Open Access
47 Citations
9,848 Views
18 Pages

23 November 2020

Duchenne muscular dystrophy (DMD) is a fatal neuromuscular disorder generally caused by out-of-frame mutations in the DMD gene. In contrast, in-frame mutations usually give rise to the milder Becker muscular dystrophy (BMD). However, this reading fra...

(This article belongs to the Special Issue Understanding Neuromuscular Health and Disease: Advances in Genetics, Omics, and Molecular Function)
  • Article
  • Open Access
12 Citations
3,256 Views
10 Pages

Older adults with disease and disability are particularly vulnerable to experiencing more severe consequences of depression. The purpose of the present study is to investigate the relationship between disease comorbidities (number of disease: ND0, 1...

(This article belongs to the Special Issue Exercise Medicine in Health and Disease)
  • Article
  • Open Access
9 Citations
6,520 Views
15 Pages

Mitochonic Acid 5 Improves Duchenne Muscular Dystrophy and Parkinson’s Disease Model of Caenorhabditis elegans

  • Xintong Wu,
  • Satoi Nagasawa,
  • Kasumi Muto,
  • Maiko Ueda,
  • Chitose Suzuki,
  • Takaaki Abe and
  • Atsushi Higashitani

24 August 2022

Mitochonic Acid 5 (MA-5) enhances mitochondrial ATP production, restores fibroblasts from mitochondrial disease patients and extends the lifespan of the disease model “Mitomouse”. Additionally, MA-5 interacts with mitofilin and modulates...

(This article belongs to the Special Issue From Molecular Basis to Therapeutic Approaches in Skeletal Muscle Dysfunction)
  • Article
  • Open Access
8 Citations
2,943 Views
12 Pages

A Modular Genetic Approach to Newborn Screening from Spinal Muscular Atrophy to Sickle Cell Disease—Results from Six Years of Genetic Newborn Screening

  • Jessica Bzdok,
  • Ludwig Czibere,
  • Siegfried Burggraf,
  • Natalie Pauly,
  • Esther M. Maier,
  • Wulf Röschinger,
  • Marc Becker and
  • Jürgen Durner

13 November 2024

Background/Objectives: Genetic newborn screening (NBS) has already entered the phase of common practice in many countries. In Germany, spinal muscular atrophy (SMA), severe combined immunodeficiency (SCID) and sickle cell disease (SCD) are currently...

(This article belongs to the Special Issue Genetic Newborn Screening)
  • Article
  • Open Access
4 Citations
2,912 Views
23 Pages

18 September 2024

Dysregulated RNA metabolism caused by SMN deficiency leads to motor neuron disease spinal muscular atrophy (SMA). Current therapies improve patient outcomes but achieve no definite cure, prompting renewed efforts to better understand disease mechanis...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Article
  • Open Access
7 Citations
3,270 Views
9 Pages

Prevalence of Pain within Limb Girdle Muscular Dystrophy R9 and Implications for Other Degenerative Diseases

  • Mark Richardson,
  • Anna Mayhew,
  • Robert Muni-Lofra,
  • Lindsay B. Murphy and
  • Volker Straub

25 November 2021

Our primary aim was to establish the prevalence of pain within limb girdle muscular dystrophy R9 (LGMDR9). As part of the Global FKRP Registry, patients are asked to complete the Short Form McGill Pain Questionnaire (SF-MPQ) annually. We used the res...

(This article belongs to the Special Issue Physiotherapy in Muscle Pain: Current Updates from Theory to Clinical Practice)
  • Article
  • Open Access
1,480 Views
11 Pages

Age- and Varicose Disease-Associated Changes in the Muscular Components of the Great Saphenous Vein

  • Khurshed A. Abduvosidov,
  • Irina A. Chekmareva,
  • Valeria G. Shestakova,
  • Irina N. Shabanova,
  • Alexander G. Alekseev,
  • Edgar S. Kafarov,
  • Alexander A. Palalov,
  • Irina N. Yashina and
  • Evgeny N. Galeysya

12 September 2025

Varicose disease and other age-related vascular illnesses are extremely prevalent among the adult population. Despite this, research devoted to involutive changes in the veins of the lower extremities is rare and fragmented. Complex morphological eva...

(This article belongs to the Section Vascular Medicine)
  • Article
  • Open Access
5 Citations
3,895 Views
8 Pages

Micronutrient Deficiency and Muscular Status in Inflammatory Bowel Disease

  • Joonhee Han,
  • Hyun Joo Song,
  • Min Sook Kang,
  • Hogyung Jun,
  • Heung Up Kim,
  • Ki Soo Kang and
  • Donghyoun Lee

1 November 2024

Micronutrient deficiencies are common in inflammatory bowel disease (IBD). The aim of this study was to evaluate micronutrient deficiencies and identify muscular status of patients with IBD. From June 2019 to October 2021, a total of 105 patients wit...

(This article belongs to the Section Micronutrients and Human Health)
  • Feature Paper
  • Review
  • Open Access
38 Citations
7,722 Views
14 Pages

3 January 2019

Induced pluripotent stem cells (iPSCs) are the foundation of modern stem cell-based regenerative medicine, especially in the case of degenerative disorders, such as muscular dystrophies (MDs). Since their introduction in 2006, many studies have used...

(This article belongs to the Special Issue Stem Cells in Personalized Medicine)
  • Review
  • Open Access
9 Citations
3,899 Views
21 Pages

Circadian clock and clock-controlled output pathways exert temporal control in diverse aspects of skeletal muscle physiology, including the maintenance of muscle mass, structure, function, and metabolism. They have emerged as significant players in u...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Review
  • Open Access
71 Citations
14,255 Views
33 Pages

Antisense Therapy in Neurology

  • Joshua J. A. Lee and
  • Toshifumi Yokota

2 August 2013

Antisense therapy is an approach to fighting diseases using short DNA-like molecules called antisense oligonucleotides. Recently, antisense therapy has emerged as an exciting and promising strategy for the treatment of various neurodegenerative and n...

  • Article
  • Open Access
19 Citations
5,745 Views
21 Pages

Nusinersen Induces Disease-Severity-Specific Neurometabolic Effects in Spinal Muscular Atrophy

  • Francesco Errico,
  • Carmen Marino,
  • Manuela Grimaldi,
  • Tommaso Nuzzo,
  • Valentina Bassareo,
  • Valeria Valsecchi,
  • Chiara Panicucci,
  • Elia Di Schiavi,
  • Tommaso Mazza and
  • Alessandro Usiello
  • + 6 authors

6 October 2022

Intrathecal delivery of Nusinersen–an antisense oligonucleotide that promotes survival motor neuron (SMN) protein induction–is an approved therapy for spinal muscular atrophy (SMA). Here, we employed nuclear magnetic resonance (NMR) spect...

(This article belongs to the Collection Feature Papers in Section 'Molecular Medicine')
  • Review
  • Open Access
32 Citations
7,568 Views
19 Pages

Muscle atrophy is an active process controlled by specific transcriptional programs, in which muscle mass is lost by increased protein degradation and/or decreased protein synthesis. This review explores the involvement of Toll-like receptors (TLRs)...

(This article belongs to the Special Issue Muscle Atrophy: Discovery of Mechanisms and Potential Therapies)
  • Review
  • Open Access
3,650 Views
10 Pages

Arterial dysfunction is major risk factor for cardiovascular complications, and arterial stiffness is an independent risk factor in end-stage renal disease patients. As the distance from the heart increases, arterial stiffness (pulse wave velocity) b...

(This article belongs to the Special Issue Feature Papers for Kidney and Dialysis: Advances in Nephrology and Dialysis)
  • Article
  • Open Access
2 Citations
2,508 Views
11 Pages

24 February 2025

Introduction: Smoking is a risk factor for chronic obstructive pulmonary disease (COPD) and lung cancer. In addition to pulmonary damages, peripheral muscle impairments are present in this population. Pulmonary limitation is observed in smokers befor...

(This article belongs to the Special Issue Innovations in Chronic Patient Management: Monitoring, Evaluation and Rehabilitation)
  • Review
  • Open Access
12 Citations
6,591 Views
27 Pages

Current Genetic Survey and Potential Gene-Targeting Therapeutics for Neuromuscular Diseases

  • Wei Chiu,
  • Ya-Hsin Hsun,
  • Kao-Jung Chang,
  • Aliaksandr A. Yarmishyn,
  • Yu-Jer Hsiao,
  • Yueh Chien,
  • Chian-Shiu Chien,
  • Chun Ma,
  • Yi-Ping Yang and
  • Hao-Min Cheng
  • + 3 authors

16 December 2020

Neuromuscular diseases (NMDs) belong to a class of functional impairments that cause dysfunctions of the motor neuron-muscle functional axis components. Inherited monogenic neuromuscular disorders encompass both muscular dystrophies and motor neuron...

(This article belongs to the Special Issue Genetic Basis and Epidemiology of Myopathies)
  • Review
  • Open Access
4 Citations
3,089 Views
19 Pages

Zebrafish as a Model Organism for Research in Rare Genetic Neuromuscular Diseases

  • Eylem Emek Akyürek,
  • Martina Erba,
  • Francesco Dalla Barba,
  • Dorianna Sandonà and
  • Roberta Sacchetto

10 September 2025

The zebrafish (Danio rerio) has become one of the most popular and valuable model organisms for studying rare neuromuscular diseases. Its unique characteristics, including the high number of offspring produced with each mating, transparent eggs, rapi...

(This article belongs to the Special Issue Rare Genetic Diseases: From Molecular Mechanisms to Therapeutic Strategies)
  • Review
  • Open Access
13 Citations
5,776 Views
24 Pages

Functional Implications of Protein Arginine Methyltransferases (PRMTs) in Neurodegenerative Diseases

  • Efthalia Angelopoulou,
  • Efstratios-Stylianos Pyrgelis,
  • Chetana Ahire,
  • Prachi Suman,
  • Awanish Mishra and
  • Christina Piperi

20 September 2023

During the aging of the global population, the prevalence of neurodegenerative diseases will be continuously growing. Although each disorder is characterized by disease-specific protein accumulations, several common pathophysiological mechanisms enco...

(This article belongs to the Special Issue Epigenetic Modifications and Changes in Neurodegenerative Diseases)
  • Article
  • Open Access
38 Citations
7,866 Views
17 Pages

Lamin A/C Assembly Defects in LMNA-Congenital Muscular Dystrophy Is Responsible for the Increased Severity of the Disease Compared with Emery–Dreifuss Muscular Dystrophy

  • Anne T. Bertrand,
  • Astrid Brull,
  • Feriel Azibani,
  • Louise Benarroch,
  • Khadija Chikhaoui,
  • Colin L. Stewart,
  • Ohad Medalia,
  • Rabah Ben Yaou and
  • Gisèle Bonne

31 March 2020

LMNA encodes for Lamin A/C, type V intermediate filaments that polymerize under the inner nuclear membrane to form the nuclear lamina. A small fraction of Lamin A/C, less polymerized, is also found in the nucleoplasm. Lamin A/C functions include role...

(This article belongs to the Special Issue The New Frontier of Therapies for Nuclear Envelope and Lamin-Related Diseases: Selected Papers from 2019 International Meeting on Laminopathies)
  • Article
  • Open Access
4 Citations
2,935 Views
14 Pages

Circulating Nrf2, Glutathione, and Malondialdehyde Correlate with Disease Severity in Duchenne Muscular Dystrophy

  • Tomas Almeida-Becerril,
  • Maricela Rodríguez-Cruz,
  • Judith Villa-Morales,
  • Christian Ricardo Sánchez-Mendoza and
  • Jose Emilio Galeazzi-Aguilar

Oxidative stress (OS) plays an essential role in the pathophysiology of Duchenne muscular dystrophy (DMD). However, the actors that regulate OS need to be better studied. We aimed to evaluate whether NFE2-like bZIP transcription factor 2 (Nrf2), glut...

(This article belongs to the Special Issue New Functions of Reactive Oxygen Species in Skeletal Muscle: From Regulatory Activities to Pathophysiological Conditions)
  • Article
  • Open Access
12 Citations
3,861 Views
9 Pages

Expanding the Phenotype of B3GALNT2-Related Disorders

  • Erika D’haenens,
  • Sarah Vergult,
  • Björn Menten,
  • Annelies Dheedene,
  • R. Frank Kooy and
  • Bert Callewaert

14 April 2022

Dystroglycanopathies are a group of congenital muscular dystrophies (CMDs) that include a broad phenotypic spectrum ranging from late-onset limb-girdle muscular dystrophy to severe muscle–eye–brain disease, Walker–Warburg syndrome,...

(This article belongs to the Section Technologies and Resources for Genetics)
  • Review
  • Open Access
20 Citations
14,317 Views
18 Pages

Pathophysiology and Management of Fatigue in Neuromuscular Diseases

  • Francesca Torri,
  • Piervito Lopriore,
  • Vincenzo Montano,
  • Gabriele Siciliano,
  • Michelangelo Mancuso and
  • Giulia Ricci

Fatigue is a major determinant of quality of life and motor function in patients affected by several neuromuscular diseases, each of them characterized by a peculiar physiopathology and the involvement of numerous interplaying factors. This narrative...

(This article belongs to the Special Issue Molecular Mechanisms, Pathophysiology and Phenotypes of Mitochondrial Disorders)
  • Review
  • Open Access
37 Citations
9,193 Views
30 Pages

Mitochondrial Dysfunction in Spinal Muscular Atrophy

  • Eleonora Zilio,
  • Valentina Piano and
  • Brunhilde Wirth

17 September 2022

Spinal muscular atrophy (SMA) is a devastating neuromuscular disorder caused by recessive mutations in the SMN1 gene, globally affecting ~8–14 newborns per 100,000. The severity of the disease depends on the residual levels of functional surviv...

(This article belongs to the Special Issue Mitochondrial Dysfunction: A Metabolic, Cardiovascular, Neurodegenerative and Neuromuscular Issue)
  • Article
  • Open Access
4 Citations
3,275 Views
15 Pages

Use of the Assessment of Caregiver Experience with Neuromuscular Disease (ACEND) in Spinal Muscular Atrophy

  • Laurey Brown,
  • Katie Hoffman,
  • Chiara Corbo-Galli,
  • Siyuan Dong,
  • Katelyn Zumpf,
  • Christa Weigel,
  • Colleen Blomgren,
  • Hannah Munson,
  • Jessa Bidwell and
  • Kristin J. Krosschell
  • + 3 authors

6 February 2024

Background: Spinal muscular atrophy (SMA) has a remarkable impact on function and participation. Subsequently, the caregivers of individuals with SMA are impacted as well. Providers and the SMA community should be aware of the presence of and likely...

(This article belongs to the Special Issue Neuromuscular Disorders and Complications: In the Challenge Lies a Solution)
  • Review
  • Open Access
43 Citations
12,355 Views
25 Pages

Antisense oligonucleotides (ASOs) are short oligodeoxynucleotides designed to bind to specific regions of target mRNA. ASOs can modulate pre-mRNA splicing, increase levels of functional proteins, and decrease levels of toxic proteins. ASOs are being...

(This article belongs to the Special Issue Neurodegenerative Disease: From Molecular Basis to Therapy, 2nd Edition)
  • Case Report
  • Open Access
495 Views
9 Pages

Background and Clinical Significance: Limb-girdle muscular dystrophy R18 is a rare autosomal recessive disorder that may present with both muscular and hepatic involvement, potentially leading to diagnostic confusion. Longitudinal MRI data documentin...

(This article belongs to the Special Issue Advanced Imaging and Theranostics in Neurological Diseases)
  • Review
  • Open Access
64 Citations
15,201 Views
37 Pages

Antisense Oligonucleotide Therapy for the Nervous System: From Bench to Bedside with Emphasis on Pediatric Neurology

  • Man Amanat,
  • Christina L. Nemeth,
  • Amena Smith Fine,
  • Doris G. Leung and
  • Ali Fatemi

Antisense oligonucleotides (ASOs) are disease-modifying agents affecting protein-coding and noncoding ribonucleic acids. Depending on the chemical modification and the location of hybridization, ASOs are able to reduce the level of toxic proteins, in...

(This article belongs to the Special Issue Novel Therapeutic Approaches for Neurodegenerative Diseases Treatment)
  • Article
  • Open Access
9 Citations
4,392 Views
12 Pages

A Nonsense Variant in the DMD Gene Causes X-Linked Muscular Dystrophy in the Maine Coon Cat

  • Evy Beckers,
  • Ine Cornelis,
  • Sofie F. M. Bhatti,
  • Pascale Smets,
  • G. Diane Shelton,
  • Ling T. Guo,
  • Luc Peelman and
  • Bart J. G. Broeckx

25 October 2022

(1) Feline dystrophin-deficient muscular dystrophy (ddMD) is a fatal disease characterized by progressive weakness and degeneration of skeletal muscles and is caused by variants in the DMD gene. To date, only two feline causal variants have been iden...

(This article belongs to the Special Issue (Epi) Genetic Disorders in Companion Animals)
  • Review
  • Open Access
8 Citations
7,688 Views
22 Pages

Update on Inherited Pediatric Motor Neuron Diseases: Clinical Features and Outcome

  • Antonio Trabacca,
  • Camilla Ferrante,
  • Maria Carmela Oliva,
  • Isabella Fanizza,
  • Ivana Gallo and
  • Marta De Rinaldis

21 October 2024

Background: Inherited pediatric motor neuron diseases (MNDs) are a group of neurodegenerative disorders characterized by the degeneration of motor neurons in the brain and the spinal cord. These diseases can manifest as early as infancy and originate...

(This article belongs to the Special Issue Advances in Genetics of Motor Neuron Diseases)
  • Article
  • Open Access
10 Citations
3,202 Views
12 Pages

Decreased Muscle-to-Fat Mass Ratio Is Associated with Low Muscular Fitness and High Alanine Aminotransferase in Children and Adolescent Boys in Organized Sports Clubs

  • Kai Ushio,
  • Yukio Mikami,
  • Hiromune Obayashi,
  • Hironori Fujishita,
  • Kouki Fukuhara,
  • Tetsuhiko Sakamitsu,
  • Kazuhiko Hirata,
  • Yasunari Ikuta,
  • Hiroaki Kimura and
  • Nobuo Adachi

24 May 2021

Decreased muscle-to-fat mass ratio (MFR) is associated with pediatric nonalcoholic fatty liver disease (NAFLD) and may reduce muscular fitness. Regular exercise in sports clubs has not led to reductions in obesity in children and adolescents; they ma...

(This article belongs to the Section Gastroenterology & Hepatopancreatobiliary Medicine)
  • Article
  • Open Access
7 Citations
3,521 Views
12 Pages

Changes in pNFH Levels in Cerebrospinal Fluid and Motor Evolution after the Loading Dose with Nusinersen in Different Types of Spinal Muscular Atrophy

  • Mihaela Badina,
  • Gabriel Cristian Bejan,
  • Corina Sporea,
  • Liliana Padure,
  • Andrada Mirea,
  • Madalina-Cristina Leanca,
  • Mihaela Axente,
  • Florin Petru Grigoras,
  • Mihaela Bejan and
  • Daniela Adriana Ion
  • + 2 authors

4 July 2023

Aim and Objectives: The objective of our retrospective study was to investigate the changes in pNFH levels in cerebrospinal fluid, which is a reliable marker of neuronal damage, after the loading dose of nusinersen in different types of spinal muscul...

  • Study Protocol
  • Open Access
3,361 Views
9 Pages

Effects of Different Tonic, Isometric and Isometric/Vibratory Strength Training Programs on Motor Symptomatology in People with Parkinson’s Disease: Study Protocol for a Randomized Trial

  • Oscar Andrades-Ramírez,
  • David Ulloa-Díaz,
  • Francisco Guede-Rojas,
  • Sergio Araya-Sierralta,
  • Gustavo Muñoz-Bustos,
  • Patricio Arroyo-Jofré and
  • Luis-Javier Chirosa-Ríos

7 July 2024

Background: The Chilean population has experienced increased longevity in recent decades, leading to an increased incidence of and mortality from neurodegenerative diseases such as Parkinson’s disease (PD). PD is a chronic degenerative conditio...

(This article belongs to the Special Issue Recent Advances in Applied Biomechanics and Sports Sciences)
  • Review
  • Open Access
2 Citations
1,897 Views
38 Pages

22 April 2026

Skeletal muscle is vital for movement and metabolism, and its dysfunction underpins disorders like muscular dystrophy and sarcopenia, severely impacting life quality. In these diseases, various cell death pathways are pivotal, driving core pathologic...

(This article belongs to the Section Cellular Pathology)
  • Review
  • Open Access
64 Citations
7,431 Views
19 Pages

Spinal Muscular Atrophy: An Evolving Scenario through New Perspectives in Diagnosis and Advances in Therapies

  • Ilaria Angilletta,
  • Rossella Ferrante,
  • Roberta Giansante,
  • Lucia Lombardi,
  • Alessandra Babore,
  • Anastasia Dell’Elice,
  • Elisa Alessandrelli,
  • Stefania Notarangelo,
  • Marianna Ranaudo and
  • Claudia Rossi
  • + 3 authors

3 October 2023

Spinal muscular atrophy (SMA) linked to 5q is a recessive motor neuron disease characterized by progressive and diffuse weakness and muscular atrophy. SMA is the most common neurodegenerative disease in childhood with an incidence of approximately 1...

(This article belongs to the Special Issue Neuromuscular Diseases: From Pathogenic Mechanisms to Therapy)
  • Article
  • Open Access
37 Citations
6,103 Views
21 Pages

Dysregulation of Muscle-Specific MicroRNAs as Common Pathogenic Feature Associated with Muscle Atrophy in ALS, SMA and SBMA: Evidence from Animal Models and Human Patients

  • Claudia Malacarne,
  • Mariarita Galbiati,
  • Eleonora Giagnorio,
  • Paola Cavalcante,
  • Franco Salerno,
  • Francesca Andreetta,
  • Cinza Cagnoli,
  • Michela Taiana,
  • Monica Nizzardo and
  • Stefania Marcuzzo
  • + 14 authors

Motor neuron diseases (MNDs) are neurodegenerative disorders characterized by upper and/or lower MN loss. MNDs include amyotrophic lateral sclerosis (ALS), spinal muscular atrophy (SMA), and spinal and bulbar muscular atrophy (SBMA). Despite variabil...

(This article belongs to the Section Molecular Neurobiology)
  • Article
  • Open Access
20 Citations
4,656 Views
13 Pages

Transcriptomic Analysis Reveals Involvement of the Macrophage Migration Inhibitory Factor Gene Network in Duchenne Muscular Dystrophy

  • Salvo Danilo Lombardo,
  • Emanuela Mazzon,
  • Katia Mangano,
  • Maria Sofia Basile,
  • Eugenio Cavalli,
  • Santa Mammana,
  • Paolo Fagone,
  • Ferdinando Nicoletti and
  • Maria Cristina Petralia

18 November 2019

Duchenne muscular dystrophy (DMD) is a progressive hereditary muscular disease with X-linked recessive inheritance, that leads patients to premature death. The loss of dystrophin determines membrane instability, causing cell damage and inflammatory r...

  • Review
  • Open Access
53 Citations
12,805 Views
22 Pages

A Role for Caveolin-3 in the Pathogenesis of Muscular Dystrophies

  • Bhola Shankar Pradhan and
  • Tomasz J. Prószyński

19 November 2020

Caveolae are the cholesterol-rich small invaginations of the plasma membrane present in many cell types including adipocytes, endothelial cells, epithelial cells, fibroblasts, smooth muscles, skeletal muscles and cardiac muscles. They serve as specia...

(This article belongs to the Special Issue Muscle Atrophy: Discovery of Mechanisms and Potential Therapies)
  • Review
  • Open Access
2 Citations
2,635 Views
23 Pages

Progress of Research on the Metabolic Regulation of Lactylation in Muscle Tissues and Its Disease Associations

  • Zhihang Wang,
  • Ji Zhang,
  • Junxi Wu,
  • Guangrun Liu,
  • Yun He,
  • Hongbo Zhao,
  • Xiaolin Jiang and
  • Shengbo Yang

30 January 2026

Lactylation serves as a vital link between cellular metabolism and epigenetic regulation and plays a pivotal role in muscle biology. Muscle tissue is the primary site of lactate production; its unique metabolic environment confers dynamism, specifici...

(This article belongs to the Section Molecular Biology)
  • Review
  • Open Access
5 Citations
5,896 Views
52 Pages

23 September 2020

The ultimate goal of precision disease modeling is to artificially recreate the disease of affected people in a highly controllable and adaptable external environment. This field has rapidly advanced which is evident from the application of patient-s...

(This article belongs to the Special Issue From hIPSCs to Adult Cells in a Dish: Promises and Pitfalls)
  • Review
  • Open Access
8 Citations
9,170 Views
10 Pages

Duchenne Muscular Dystrophy Newborn Screening, a Case Study for Examining Ethical and Legal Issues for Pilots for Emerging Disorders: Considerations and Recommendations

  • Michele A. Lloyd-Puryear,
  • Thomas O. Crawford,
  • Amy Brower,
  • Kristin Stephenson,
  • Tracy Trotter,
  • Edward Goldman,
  • Aaron Goldenberg,
  • R. Rodney Howell,
  • Annie Kennedy and
  • Michael Watson

Duchenne muscular dystrophy (DMD/Duchenne) is one of the ten most severe and common pediatric genetic diseases and affects an estimated 1 in every 5000 male births. While Duchenne is a 100% fatal disease, the clinical community has demonstrated that...

  • Review
  • Open Access
12 Citations
6,415 Views
19 Pages

Postbiotics Derived from Lactic Acid Bacteria Fermentation: Therapeutic Potential in the Treatment of Muscular Complications in Inflammatory Bowel Disease

  • Emili Bruna Toso Bueno,
  • Kimberlly de Oliveira Silva,
  • Maria Eduarda Ferraz Mendes,
  • Lívia Batista de Oliveira,
  • Felipe Prado de Menezes,
  • Anna Cardoso Imperador,
  • Lucimeire Fernandes Correia and
  • Lizziane Kretli Winkelstroter

Inflammatory bowel disease (IBD) is characterized by chronic inflammation in the gastrointestinal tract, which can result in several muscular complications, including sarcopenia, the loss of muscle mass, and impaired muscle function. Recently, postbi...

(This article belongs to the Topic News and Updates on Probiotics)
  • Article
  • Open Access
2 Citations
1,482 Views
13 Pages

8 November 2025

Background: The COVID-19 pandemic disrupted healthcare systems, disproportionately affecting individuals with rare diseases. This study explores the health-related quality of life and financial burden in the post-pandemic context among children with...

(This article belongs to the Special Issue Performance of Healthcare Systems During and After the COVID-19 Pandemic)
  • Feature Paper
  • Review
  • Open Access
14 Citations
5,833 Views
21 Pages

TRIM32 and Malin in Neurological and Neuromuscular Rare Diseases

  • Lorena Kumarasinghe,
  • Lu Xiong,
  • Maria Adelaida Garcia-Gimeno,
  • Elisa Lazzari,
  • Pascual Sanz and
  • Germana Meroni

6 April 2021

Tripartite motif (TRIM) proteins are RING E3 ubiquitin ligases defined by a shared domain structure. Several of them are implicated in rare genetic diseases, and mutations in TRIM32 and TRIM-like malin are associated with Limb-Girdle Muscular Dystrop...

(This article belongs to the Special Issue Cellular Function of TRIM E3 Ubiquitin Ligases in Health and Disease)
  • Article
  • Open Access
822 Views
20 Pages

Urinary Proteome Profiling by Several Methods Identifies Titin as the Most-Differentiating Noninvasive Urinary Biomarker of Disease Severity in Becker Muscular Dystrophy

  • Kimchi K. Le,
  • Emily H. Canessa,
  • Corrine M. Stahura,
  • Jenna Mayers,
  • Katie A. Edwards,
  • Marissa Barbieri,
  • Eric P. Hoffman and
  • Yetrib Hathout

Background: Beckers muscular dystrophy (BMD) is a clinically heterogeneous dystrophinopathy caused by in-frame mutations in the dystrophin gene, resulting in variable disease severity. This variability limits the effectiveness of standardized functio...

(This article belongs to the Special Issue Clinical Proteomics: Unravelling Drug and Disease Mechanisms (Fifth Edition))
  • Case Report
  • Open Access
1 Citations
2,398 Views
11 Pages

Heterotopic Ossification of the Adductor Muscles in Bald Eagles (Haliaeetus leucocephalus)

  • Marko Legler,
  • Katja von Dörnberg,
  • Peter Wohlsein and
  • Michael Fehr

10 November 2024

Diseases of the musculature can be caused, for example, by alimentary or traumatic issues. In three bald eagles with painful lameness and/or a reduced range of the hip joint, a muscular disease was diagnosed via radiographic examination. The eagles w...

(This article belongs to the Section Anatomy, Histology and Pathology)
  • Article
  • Open Access
13 Citations
5,183 Views
13 Pages

Validation of Chemokine Biomarkers in Duchenne Muscular Dystrophy

  • Michael Ogundele,
  • Jesslyn S. Zhang,
  • Mansi V. Goswami,
  • Marissa L. Barbieri,
  • Utkarsh J. Dang,
  • James S. Novak,
  • Eric P. Hoffman,
  • Kanneboyina Nagaraju,
  • CINRG-DNHS Investigators and
  • Yetrib Hathout

13 August 2021

Duchenne muscular dystrophy (DMD) is a progressive muscle disease involving complex skeletal muscle pathogenesis. The pathogenesis is triggered by sarcolemma instability due to the lack of dystrophin protein expression, leading to Ca2+ influx, muscle...

(This article belongs to the Special Issue Duchenne Muscular Dystrophy: Mechanisms and Therapeutic Strategies)
  • Review
  • Open Access
1,262 Views
26 Pages

Genetic Mutations Underlying Growth Impairment and Cardiomyopathies in Children: Molecular Mechanisms, Clinical Implications and Targeted Therapies

  • Marco Maria Dicorato,
  • Gaia De Sario,
  • Maria Cristina Carella,
  • Andrea Igoren Guaricci,
  • Marco Matteo Ciccone,
  • Cinzia Forleo,
  • Gabriele D’Amato and
  • Maria Felicia Faienza

23 March 2026

Growth impairment is a clinical manifestation frequently observed in pediatric patients with cardiomyopathy associated with various inherited disorders, including RASopathies, lysosomal storage diseases, neuromuscular disorders, and metabolic conditi...

(This article belongs to the Special Issue Genetic and Molecular Insights into Cardiovascular Disease: From Mechanisms to Precision Medicine)
  • Review
  • Open Access
25 Citations
6,239 Views
17 Pages

How Inflammation Pathways Contribute to Cell Death in Neuro-Muscular Disorders

  • Sara Salucci,
  • Anna Bartoletti Stella,
  • Michela Battistelli,
  • Sabrina Burattini,
  • Alberto Bavelloni,
  • Lucio Ildebrando Cocco,
  • Pietro Gobbi and
  • Irene Faenza

28 July 2021

Neuro-muscular disorders include a variety of diseases induced by genetic mutations resulting in muscle weakness and waste, swallowing and breathing difficulties. However, muscle alterations and nerve depletions involve specific molecular and cellula...

(This article belongs to the Special Issue Inflammatory Pathways in Neuro-Muscular Degeneration, Metabolic Syndromes, Cancer and Infection)
  • Review
  • Open Access
78 Citations
9,870 Views
20 Pages

The term “neurodegenerative diseases” (NDs) identifies a group of heterogeneous diseases characterized by progressive loss of selectively vulnerable populations of neurons, which progressively deteriorates over time, leading to neuronal d...

(This article belongs to the Section Molecular Neurobiology)

of 29